MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12185-025-04132-8

Медицинская библиотека · International journal of hematology · 2025

Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia.

Suzuki Kohjin, Takaku Tomoiku, Watanabe Naoki, Iriyama Noriyoshi, Iwanaga Eisaku, Kimura Yuta, Ishikawa Maho, Nakayama Hitomi, Sato Eriko, Tabayashi Takayuki, Mitsumori Toru, Nakazato Tomonori, Tokuhira Michihide, Fujita Hiroyuki, Ando Miki, Hatta Yoshihiro, Kawaguchi Tatsuya

СтатьяПеревод в очереди

Аннотация

The European LeukemiaNet recommendations for the management of chronic myeloid leukemia (CML) consider achievement of major molecular response (MMR) within 12 months to be an optimal response (OR). However, no currently available tool can predict treatment response at diagnosis. This study aimed to develop a predictive scoring tool for OR and subsequent deep molecular response (DMR) using peripheral blood parameters at diagnosis. A retrospective analysis was conducted in 535 patients with CML from the CML Cooperative Study Group database. Patients were categorized into OR (MMR within 12 months; n = 355) and non-OR groups (MMR after 13 months; n = 180). Logistic regression analysis identified white blood cell count, platelet count, eosinophil percentage, and imatinib use as significant predictors of OR. These variables were used to construct a novel score. The score was significantly higher in the non-OR group and showed superior predictive accuracy for OR compared with existing prognostic scores. Furthermore, lower scores correlated with higher rates of DMR achievement. Notably, the score effectively predicted OR achievement among patients with low/intermediate ELTS risk treated with imatinib. This new scoring tool may facilitate individualized treatment selection in CML, guiding upfront tyrosine kinase inhibitor selection and advancing precision medicine.

Для цитирования: Suzuki Kohjin, Takaku Tomoiku, Watanabe Naoki, Iriyama Noriyoshi, Iwanaga Eisaku, Kimura Yuta, Ishikawa Maho, Nakayama Hitomi, Sato Eriko, Tabayashi Takayuki, Mitsumori Toru, Nakazato Tomonori, Tokuhira Michihide, Fujita Hiroyuki, Ando Miki, Hatta Yoshihiro, Kawaguchi Tatsuya. Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia.. International journal of hematology. 2025. DOI: 10.1007/s12185-025-04132-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.